Elicio Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Elicio Therapeutics has a total shareholder equity of $11.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $27.1M and $15.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$12.89m |
Equity | US$11.37m |
Total liabilities | US$15.77m |
Total assets | US$27.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ELTX's short term assets ($16.3M) exceed its short term liabilities ($9.8M).
Long Term Liabilities: ELTX's short term assets ($16.3M) exceed its long term liabilities ($6.0M).
Debt to Equity History and Analysis
Debt Level: ELTX is debt free.
Reducing Debt: ELTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ELTX has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ELTX is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.